Daniela A. Bota

7.8k total citations · 1 hit paper
149 papers, 3.5k citations indexed

About

Daniela A. Bota is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniela A. Bota has authored 149 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Genetics, 40 papers in Molecular Biology and 37 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniela A. Bota's work include Glioma Diagnosis and Treatment (94 papers), Brain Metastases and Treatment (20 papers) and Cancer Research and Treatments (20 papers). Daniela A. Bota is often cited by papers focused on Glioma Diagnosis and Treatment (94 papers), Brain Metastases and Treatment (20 papers) and Cancer Research and Treatments (20 papers). Daniela A. Bota collaborates with scholars based in United States, Netherlands and Canada. Daniela A. Bota's co-authors include Kelvin J.A. Davies, Kaijun Di, Jenny K. Ngo, Holly Van Remmen, Naomi Lomeli, Mark E. Linskey, Daniela Alexandru, Xing Gong, Annick Desjardins and Peter Chang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Daniela A. Bota

134 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas

2018 325 citations Daniela A. Bota et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniela A. Bota United States	30	1.5k	1.1k	585	528	431	149	3.5k
George Α. Alexiou Greece	31	1.0k 0.7×	1.0k 0.9×	444 0.8×	419 0.8×	625 1.5×	240	3.7k
Hannu Haapasalo Finland	39	2.4k 1.6×	1.1k 1.0×	483 0.8×	854 1.6×	321 0.7×	131	4.9k
Shinichi Yoshimura Japan	29	1.4k 1.0×	856 0.8×	227 0.4×	268 0.5×	248 0.6×	98	3.3k
Andree Blaukat Germany	31	2.1k 1.4×	478 0.4×	342 0.6×	803 1.5×	275 0.6×	94	3.6k
Therese A. Dolecek United States	25	1.0k 0.7×	2.2k 2.0×	789 1.3×	648 1.2×	464 1.1×	45	4.8k
Laila Poisson United States	32	1.3k 0.8×	1.0k 0.9×	454 0.8×	401 0.8×	917 2.1×	108	3.6k
Joshua L. Dunaief United States	45	3.6k 2.4×	676 0.6×	366 0.6×	425 0.8×	1.1k 2.6×	146	6.9k
Amyn M. Rojiani United States	40	2.7k 1.8×	747 0.7×	739 1.3×	693 1.3×	341 0.8×	139	5.9k
Susan Short United Kingdom	35	1.4k 0.9×	1.0k 0.9×	1.2k 2.0×	708 1.3×	1.5k 3.5×	159	4.2k

Countries citing papers authored by Daniela A. Bota

Since Specialization

Citations

This map shows the geographic impact of Daniela A. Bota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela A. Bota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela A. Bota more than expected).

Fields of papers citing papers by Daniela A. Bota

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela A. Bota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela A. Bota. The network helps show where Daniela A. Bota may publish in the future.

Co-authorship network of co-authors of Daniela A. Bota

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela A. Bota. A scholar is included among the top collaborators of Daniela A. Bota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela A. Bota. Daniela A. Bota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Argueta, Donovan A., et al.. (2025). Neuronal p38 MAPK Signaling Contributes to Cisplatin-Induced Peripheral Neuropathy. Antioxidants. 14(4). 445–445.

Bota, Daniela A., David Piccioni, Christopher Duma, et al.. (2025). Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival. Human Vaccines & Immunotherapeutics. 21(1). 2556591–2556591.

Kong, Xiao–Tang, et al.. (2024). CTNI-81. PROPOSAL FOR A PHASE IB PILOT CLINICAL TRIAL TO STUDY SAFETY AND IMPROVING ANTI-NEOPLASTIC ADVERSE EFFECTS BY ADDITION OF NATURAL MARINE PRODUCT FUCOIDAN TO THE STANDARD THERAPY FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM). Neuro-Oncology. 26(Supplement_8). viii116–viii116.

Merrell, Ryan, Patrick Y. Wen, Deborah Forst, et al.. (2024). Randomized phase IIb trial of a CMV vaccine immunotherapeutic candidate (VBI-1901) in recurrent glioblastomas.. Journal of Clinical Oncology. 42(16_suppl). TPS2100–TPS2100. 2 indexed citations

Lomeli, Naomi, et al.. (2024). N-acetylcysteine prevents cisplatin-induced cognitive impairments in an ovarian cancer rat model. Cancer Letters. 611. 217405–217405. 3 indexed citations

Lomeli, Naomi, Kaijun Di, Nitesh Kumar Nandwana, et al.. (2023). Discovery and Validation of Novel LonP1 and Proteasome Inhibitor in IDH1-R132H Malignant Astrocytoma Models. SSRN Electronic Journal. 2 indexed citations

Das, Bhaskar C., et al.. (2023). Identification of new hit to lead magmas inhibitors as potential therapeutics for glioblastoma. Bioorganic & Medicinal Chemistry Letters. 91. 129330–129330. 1 indexed citations

Lomeli, Naomi, et al.. (2023). LonP1 Drives Proneural Mesenchymal Transition in IDH1-R132H Diffuse Glioma. SSRN Electronic Journal. 1 indexed citations

Lomeli, Naomi, et al.. (2021). Cognitive complications of cancer and cancer-related treatments – Novel paradigms. Neuroscience Letters. 749. 135720–135720. 15 indexed citations

10.

Cinar, Pelin, Richard J. Bold, Daniela A. Bota, et al.. (2020). Planning for post‐pandemic cancer care delivery: Recovery or opportunity for redesign?. CA A Cancer Journal for Clinicians. 71(1). 34–46. 14 indexed citations

11.

Bota, Daniela A., Jose Carrillo, Frank P. K. Hsu, et al.. (2018). Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma : interim results and correlations with CD4+ T-lymphocyte counts. JAMA Oncology. 7(3). 3 indexed citations

12.

Sahyouni, Ronald, et al.. (2018). Somatic SMARCB1 Mutation in Sporadic Multiple Meningiomas: Case Report. Frontiers in Neurology. 9. 919–919. 6 indexed citations

13.

Romero-López, Mónica, Kaijun Di, Hermann B. Frieboes, et al.. (2017). 3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care Therapy. Cancer Research. 77(15). 4171–4184. 32 indexed citations

14.

Sender, Leonard S., et al.. (2016). Cognitive Impairment in Survivors of Adolescent and Early Young Adult Onset Non-CNS Cancers: Does Chemotherapy Play a Role?. Journal of Adolescent and Young Adult Oncology. 5(3). 226–231. 16 indexed citations

15.

Mathews, Marlon S., Daniela A. Bota, Ronald C. Kim, Anton N. Hasso, & Mark E. Linskey. (2011). Primary leptomeningeal plasmablastic lymphoma. Journal of Neuro-Oncology. 104(3). 835–838. 9 indexed citations

16.

Ge, Lisheng, et al.. (2010). Immunotherapy of Brain Cancers: The Past, the Present, and Future Directions. Journal of Immunology Research. 2010(1). 296453–296453. 10 indexed citations

17.

Gong, Xing, et al.. (2010). MITOCHONDRIAL LON IS THE FIRST IDENTIFIED MITOCHONDRIAL PROTEIN TO MEDIATE HYPOXIC ADAPTATION, INVASION, AND TREATMENT RESISTANCE TO RADIATION AND TEMOZOLOMIDE IN MALIGNANT GLIOMA CELL LINES. Neuro-Oncology. 12. 14–14. 1 indexed citations

18.

Bota, Daniela A. & Daniela Alexandru. (2009). CHEMOTHERAPY TREATMENT FOR RADIATION-INDUCED FIBROSARCOMA: CASE REPORT AND REVIEW OF THE LITERATURE. Neuro-Oncology. 11(5). 629–629. 2 indexed citations

19.

Schwartz, Philip H., et al.. (2009). UNDERSTANDING THE MOLECULAR BASES OF CHEMOTHERAPY-INDUCED COGNITIVE IMPAIRMENT: NORMAL NEURAL PRECURSORS HAVE DIFFERENTIAL SENSITIVITY TO COMMONLY USED CHEMOTHERAPY DRUGS. Neuro-Oncology. 11(5). 642–642. 1 indexed citations

20.

Bota, Daniela A., Holly Van Remmen, & Kelvin J.A. Davies. (2002). Modulation of Lon protease activity and aconitase turnover during aging and oxidative stress. FEBS Letters. 532(1-2). 103–106. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact